Toledano Miranda Jayne 4
4 · Journey Medical Corp · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Journey Medical (DERM) Director Toledano Miranda Jayne Receives Award
What Happened
Toledano Miranda Jayne, a director of Journey Medical Corp (DERM), was granted 50,000 restricted stock units (RSUs) on July 1, 2026. The grant is reported at $0.00 (no cash exchanged) and represents an award under the company's 2015 Stock Plan. This is a grant/award (not a purchase or sale) and does not represent an immediate change in tradable shares.
Key Details
- Transaction date: July 1, 2026; Filing date (Form 4): July 2, 2026 (timely filing).
- Amount: 50,000 RSUs granted; reported price $0.00 (Acquired = $0).
- Vesting schedule (Footnote F1): 16,666 RSUs vest on July 1, 2029; 16,667 on July 1, 2030; 16,667 on July 1, 2031.
- Footnote F2: Confirms these are restricted stock units that vest over time.
- Shares owned after transaction: Not specified in the provided filing details.
Context
RSUs are awards that convert into shares only as they vest; they are not immediately transferable and their ultimate value depends on Journey Medical's share price at vesting. Grants to directors are common as compensation/retention — factual disclosure rather than a direct buy or sell signal. The filing appears timely (filed the day after the grant).
Insider Transaction Report
- Award
Common Stock, $0.0001 par value
[F1][F2]2026-07-01+50,000→ 168,618 total
Footnotes (2)
- [F1]On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031.
- [F2]Includes restricted stock units, which vest over various time periods.